{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T08:20:51Z","timestamp":1792570851468,"version":"4.5.0"},"reference-count":48,"publisher":"American Diabetes Association","issue":"2","license":[{"start":{"date-parts":[[2016,8,1]],"date-time":"2016-08-01T00:00:00Z","timestamp":1470009600000},"content-version":"vor","delay-in-days":273,"URL":"http:\/\/www.diabetesjournals.org\/site\/license"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["UL1-TR-000135"],"award-info":[{"award-number":["UL1-TR-000135"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["DK-78646"],"award-info":[{"award-number":["DK-78646"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["diabetesjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2016,2,1]]},"abstract":"<jats:p>The diabetes-associated allele in TCF7L2 increases the rate of conversion to diabetes; however, the mechanism by which this occurs remains elusive. We hypothesized that the diabetes-associated allele in this locus (rs7903146) impairs insulin secretion and that this defect would be exacerbated by acute free fatty acid (FFA)\u2013induced insulin resistance. We studied 120 individuals of whom one-half were homozygous for the diabetes-associated allele TT at rs7903146 and one-half were homozygous for the protective allele CC. After a screening examination during which glucose tolerance status was determined, subjects were studied on two occasions in random order while undergoing an oral challenge. During one study day, FFA was elevated by infusion of Intralipid plus heparin. On the other study day, subjects received the same amount of glycerol as present in the Intralipid infusion. \u03b2-Cell responsivity indices were estimated with the oral C-peptide minimal model. We report that \u03b2-cell responsivity was slightly impaired in the TT genotype group. Moreover, the hyperbolic relationship between insulin secretion and \u03b2-cell responsivity differed significantly between genotypes. Subjects also exhibited impaired suppression of glucagon after an oral challenge. These data imply that a genetic variant harbored within the TCF7L2 locus impairs glucose tolerance through effects on glucagon as well as on insulin secretion.<\/jats:p>","DOI":"10.2337\/db15-1233","type":"journal-article","created":{"date-parts":[[2015,11,3]],"date-time":"2015-11-03T03:13:49Z","timestamp":1446520429000},"page":"371-380","update-policy":"https:\/\/doi.org\/10.2337\/ada-journal-policies","source":"Crossref","is-referenced-by-count":55,"title":["<i>TCF7L2<\/i> Genotype and <i>\u03b1<\/i>-Cell Function in Humans Without Diabetes"],"prefix":"10.2337","volume":"65","author":[{"given":"Meera","family":"Shah","sequence":"first","affiliation":[{"name":"Division of Endocrinology, Diabetes, Metabolism, and Nutrition Research, Mayo Clinic, Rochester, MN"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ron T.","family":"Varghese","sequence":"additional","affiliation":[{"name":"Division of Endocrinology, Diabetes, Metabolism, and Nutrition Research, Mayo Clinic, Rochester, MN"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John M.","family":"Miles","sequence":"additional","affiliation":[{"name":"Division of Endocrinology, Diabetes, Metabolism, and Nutrition Research, Mayo Clinic, Rochester, MN"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Piccinini","sequence":"additional","affiliation":[{"name":"Department of Information Engineering, Universit\u00e0 degli Studi di Padova, Padova, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiara","family":"Dalla Man","sequence":"additional","affiliation":[{"name":"Department of Information Engineering, Universit\u00e0 degli Studi di Padova, Padova, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudio","family":"Cobelli","sequence":"additional","affiliation":[{"name":"Department of Information Engineering, Universit\u00e0 degli Studi di Padova, Padova, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kent R.","family":"Bailey","sequence":"additional","affiliation":[{"name":"Division of Biomedical Statistics and Informatics, Mayo Clinic, Rochester, MN"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert A.","family":"Rizza","sequence":"additional","affiliation":[{"name":"Division of Endocrinology, Diabetes, Metabolism, and Nutrition Research, Mayo Clinic, Rochester, MN"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adrian","family":"Vella","sequence":"additional","affiliation":[{"name":"Division of Endocrinology, Diabetes, Metabolism, and Nutrition Research, Mayo Clinic, Rochester, MN"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1167","published-online":{"date-parts":[[2015,11,2]]},"reference":[{"key":"2022031303570601500_B1","doi-asserted-by":"crossref","first-page":"1830","DOI":"10.2337\/db14-1504","article-title":"Sixty-five common genetic variants and prediction of type 2 diabetes","volume":"64","author":"Talmud","year":"2015","journal-title":"Diabetes"},{"key":"2022031303570601500_B2","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1056\/NEJMoa062418","article-title":"TCF7L2 polymorphisms and progression to diabetes in the Diabetes Prevention Program","volume":"355","author":"Florez","year":"2006","journal-title":"N Engl J Med"},{"key":"2022031303570601500_B3","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1038\/ng.521","article-title":"Genetic variation in GIPR influences the glucose and insulin responses to an oral glucose challenge","volume":"42","author":"Saxena","year":"2010","journal-title":"Nat Genet"},{"key":"2022031303570601500_B4","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1007\/BF01235858","article-title":"Insulin production rate following glucose ingestion estimated by splanchnic C-peptide output in normal man","volume":"17","author":"Waldh\u00e4usl","year":"1979","journal-title":"Diabetologia"},{"key":"2022031303570601500_B5","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.2337\/db13-1198","article-title":"The oral minimal model method","volume":"63","author":"Cobelli","year":"2014","journal-title":"Diabetes"},{"key":"2022031303570601500_B6","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1007\/s00125-013-3121-8","article-title":"HOMA and Matsuda indices of insulin sensitivity: poor correlation with minimal model-based estimates of insulin sensitivity in longitudinal settings","volume":"57","author":"Xiang","year":"2014","journal-title":"Diabetologia"},{"key":"2022031303570601500_B7","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1007\/s00125-009-1307-x","article-title":"The T allele of rs7903146 TCF7L2 is associated with impaired insulinotropic action of incretin hormones, reduced 24 h profiles of plasma insulin and glucagon, and increased hepatic glucose production in young healthy men","volume":"52","author":"Pilgaard","year":"2009","journal-title":"Diabetologia"},{"key":"2022031303570601500_B8","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1007\/s00125-007-0717-x","article-title":"Transcription factor 7-like 2 polymorphisms and type 2 diabetes, glucose homeostasis traits and gene expression in US participants of European and African descent","volume":"50","author":"Elbein","year":"2007","journal-title":"Diabetologia"},{"key":"2022031303570601500_B9","doi-asserted-by":"crossref","first-page":"3536","DOI":"10.2337\/db06-0319","article-title":"Pathogenesis of pre-diabetes: mechanisms of fasting and postprandial hyperglycemia in people with impaired fasting glucose and\/or impaired glucose tolerance","volume":"55","author":"Bock","year":"2006","journal-title":"Diabetes"},{"key":"2022031303570601500_B10","doi-asserted-by":"crossref","first-page":"456","DOI":"10.2337\/dc08-1274","article-title":"Primary defects in beta-cell function further exacerbated by worsening of insulin resistance mark the development of impaired glucose tolerance in obese adolescents","volume":"32","author":"Cali","year":"2009","journal-title":"Diabetes Care"},{"key":"2022031303570601500_B11","doi-asserted-by":"crossref","first-page":"335","DOI":"10.2337\/dc08-1478","article-title":"Oral disposition index predicts the development of future diabetes above and beyond fasting and 2-h glucose levels","volume":"32","author":"Utzschneider","year":"2009","journal-title":"Diabetes Care"},{"key":"2022031303570601500_B12","doi-asserted-by":"crossref","first-page":"3","DOI":"10.2337\/diab.46.1.3","article-title":"Role of fatty acids in the pathogenesis of insulin resistance and NIDDM","volume":"46","author":"Boden","year":"1997","journal-title":"Diabetes"},{"key":"2022031303570601500_B13","doi-asserted-by":"crossref","first-page":"301","DOI":"10.2337\/diabetes.51.2.301","article-title":"Effects of free fatty acids and glycerol on splanchnic glucose metabolism and insulin extraction in nondiabetic humans","volume":"51","author":"Shah","year":"2002","journal-title":"Diabetes"},{"key":"2022031303570601500_B14","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/S0022-2275(20)38029-9","article-title":"A microfluorometric method for the determination of free fatty acids in plasma","volume":"24","author":"Miles","year":"1983","journal-title":"J Lipid Res"},{"key":"2022031303570601500_B15","first-page":"E431","article-title":"Validation of a new method for determination of free fatty acid turnover","volume":"252","author":"Miles","year":"1987","journal-title":"Am J Physiol"},{"key":"2022031303570601500_B16","doi-asserted-by":"crossref","first-page":"E637","DOI":"10.1152\/ajpendo.00319.2003","article-title":"Minimal model estimation of glucose absorption and insulin sensitivity from oral test: validation with a tracer method","volume":"287","author":"Dalla Man","year":"2004","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"2022031303570601500_B17","doi-asserted-by":"crossref","first-page":"150","DOI":"10.2337\/diabetes.50.1.150","article-title":"Oral glucose tolerance test minimal model indexes of beta-cell function and insulin sensitivity","volume":"50","author":"Breda","year":"2001","journal-title":"Diabetes"},{"key":"2022031303570601500_B18","doi-asserted-by":"crossref","first-page":"368","DOI":"10.2337\/diabetes.41.3.368","article-title":"Estimation of insulin secretion rates from C-peptide levels. Comparison of individual and standard kinetic parameters for C-peptide clearance","volume":"41","author":"Van Cauter","year":"1992","journal-title":"Diabetes"},{"key":"2022031303570601500_B19","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1109\/RBME.2009.2036073","article-title":"Diabetes: models, signals, and control","volume":"2","author":"Cobelli","year":"2009","journal-title":"IEEE Rev Biomed Eng"},{"key":"2022031303570601500_B20","doi-asserted-by":"crossref","first-page":"E576","DOI":"10.1152\/ajpendo.00139.2011","article-title":"The disposition index: from individual to population approach","volume":"303","author":"Denti","year":"2012","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"2022031303570601500_B21","doi-asserted-by":"crossref","first-page":"3109","DOI":"10.1002\/1097-0258(20001130)19:22<3109::AID-SIM558>3.0.CO;2-F","article-title":"Sympercents: symmetric percentage differences on the 100 log(e) scale simplify the presentation of log transformed data","volume":"19","author":"Cole","year":"2000","journal-title":"Stat Med"},{"key":"2022031303570601500_B22","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1038\/ng1960","article-title":"Refining the impact of TCF7L2 gene variants on type 2 diabetes and adaptive evolution","volume":"39","author":"Helgason","year":"2007","journal-title":"Nat Genet"},{"key":"2022031303570601500_B23","doi-asserted-by":"crossref","first-page":"4013","DOI":"10.1210\/jc.2008-0855","article-title":"Impact of TCF7L2 rs7903146 on insulin secretion and action in young and elderly Danish twins","volume":"93","author":"Wegner","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"2022031303570601500_B24","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1007\/s00125-008-0926-y","article-title":"Polymorphisms in the TCF7L2, CDKAL1 and SLC30A8 genes are associated with impaired proinsulin conversion","volume":"51","author":"Kirchhoff","year":"2008","journal-title":"Diabetologia"},{"key":"2022031303570601500_B25","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.2337\/db09-1568","article-title":"Detailed physiologic characterization reveals diverse mechanisms for novel genetic loci regulating glucose and insulin metabolism in humans","volume":"59","author":"Ingelsson","year":"2010","journal-title":"Diabetes"},{"key":"2022031303570601500_B26","doi-asserted-by":"crossref","first-page":"3575","DOI":"10.1210\/jc.2009-0609","article-title":"Genetic variants of TCF7L2 are associated with insulin resistance and related metabolic phenotypes in Taiwanese adolescents and Caucasian young adults","volume":"94","author":"Liu","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"2022031303570601500_B27","doi-asserted-by":"crossref","first-page":"2654","DOI":"10.2337\/db06-0338","article-title":"Polymorphisms in the transcription factor 7-like 2 (TCF7L2) gene are associated with type 2 diabetes in the Amish: replication and evidence for a role in both insulin secretion and insulin resistance","volume":"55","author":"Damcott","year":"2006","journal-title":"Diabetes"},{"key":"2022031303570601500_B28","doi-asserted-by":"crossref","first-page":"73","DOI":"10.2337\/diab.40.1.73","article-title":"Contribution to postprandial hyperglycemia and effect on initial splanchnic glucose clearance of hepatic glucose cycling in glucose-intolerant or NIDDM patients","volume":"40","author":"Butler","year":"1991","journal-title":"Diabetes"},{"key":"2022031303570601500_B29","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/S0026-0495(98)90185-8","article-title":"Effects of glucagon on postprandial carbohydrate metabolism in nondiabetic humans","volume":"47","author":"Frank","year":"1998","journal-title":"Metabolism"},{"key":"2022031303570601500_B30","first-page":"E283","article-title":"Impact of lack of suppression of glucagon on glucose tolerance in humans","volume":"277","author":"Shah","year":"1999","journal-title":"Am J Physiol"},{"key":"2022031303570601500_B31","first-page":"4053","article-title":"Lack of suppression of glucagon contributes to postprandial hyperglycemia in subjects with type 2 diabetes mellitus","volume":"85","author":"Shah","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"key":"2022031303570601500_B32","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.2337\/db11-1732","article-title":"Diabetes-associated common genetic variation and its association with GLP-1 concentrations and response to exogenous GLP-1","volume":"61","author":"Smushkin","year":"2012","journal-title":"Diabetes"},{"key":"2022031303570601500_B33","doi-asserted-by":"crossref","first-page":"2155","DOI":"10.1172\/JCI30706","article-title":"Mechanisms by which common variants in the TCF7L2 gene increase risk of type 2 diabetes","volume":"117","author":"Lyssenko","year":"2007","journal-title":"J Clin Invest"},{"key":"2022031303570601500_B34","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1111\/j.1463-1326.2012.01675.x","article-title":"Incretin and pancreatic hormone secretion in Caucasian non-diabetic carriers of the TCF7L2 rs7903146 risk T allele","volume":"15","author":"F\u00e6rch","year":"2013","journal-title":"Diabetes Obes Metab"},{"key":"2022031303570601500_B35","doi-asserted-by":"crossref","first-page":"678","DOI":"10.2337\/db07-1124","article-title":"Predictors of incretin concentrations in subjects with normal, impaired, and diabetic glucose tolerance","volume":"57","author":"Vollmer","year":"2008","journal-title":"Diabetes"},{"key":"2022031303570601500_B36","doi-asserted-by":"crossref","first-page":"951","DOI":"10.2337\/diabetes.51.4.951","article-title":"Impaired beta-cell function, incretin effect, and glucagon suppression in patients with type 1 diabetes who have normal fasting glucose","volume":"51","author":"Greenbaum","year":"2002","journal-title":"Diabetes"},{"key":"2022031303570601500_B37","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.1007\/s00125-014-3264-2","article-title":"Glucagon responses to increasing oral loads of glucose and corresponding isoglycaemic intravenous glucose infusions in patients with type 2 diabetes and healthy individuals","volume":"57","author":"Bagger","year":"2014","journal-title":"Diabetologia"},{"key":"2022031303570601500_B38","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1210\/edrv.20.6.0385","article-title":"The glucagon-like peptides","volume":"20","author":"Kieffer","year":"1999","journal-title":"Endocr Rev"},{"key":"2022031303570601500_B39","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1074\/jbc.M411487200","article-title":"TCF-4 mediates cell type-specific regulation of proglucagon gene expression by beta-catenin and glycogen synthase kinase-3beta","volume":"280","author":"Yi","year":"2005","journal-title":"J Biol Chem"},{"key":"2022031303570601500_B40","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1038\/ng1732","article-title":"Variant of transcription factor 7-like 2 (TCF7L2) gene confers risk of type 2 diabetes","volume":"38","author":"Grant","year":"2006","journal-title":"Nat Genet"},{"key":"2022031303570601500_B41","doi-asserted-by":"crossref","first-page":"2443","DOI":"10.1007\/s00125-007-0753-6","article-title":"Impaired glucagon-like peptide-1-induced insulin secretion in carriers of transcription factor 7-like 2 (TCF7L2) gene polymorphisms [published corrections appear in Diabetologia 2008;51:208 and Diabetologia 2009;52:557]","volume":"50","author":"Sch\u00e4fer","year":"2007","journal-title":"Diabetologia"},{"key":"2022031303570601500_B42","doi-asserted-by":"crossref","first-page":"2388","DOI":"10.1093\/hmg\/ddp178","article-title":"Decreased TCF7L2 protein levels in type 2 diabetes mellitus correlate with downregulation of GIP- and GLP-1 receptors and impaired beta-cell function","volume":"18","author":"Shu","year":"2009","journal-title":"Hum Mol Genet"},{"key":"2022031303570601500_B43","doi-asserted-by":"crossref","first-page":"2677","DOI":"10.1007\/s00125-012-2660-8","article-title":"TCF7L2 rs7903146 impairs islet function and morphology in non-diabetic individuals","volume":"55","author":"Le Bacquer","year":"2012","journal-title":"Diabetologia"},{"key":"2022031303570601500_B44","doi-asserted-by":"crossref","first-page":"3630","DOI":"10.2337\/db06-0574","article-title":"Polymorphism in the transcription factor 7-like 2 (TCF7L2) gene is associated with reduced insulin secretion in nondiabetic women","volume":"55","author":"Munoz","year":"2006","journal-title":"Diabetes"},{"key":"2022031303570601500_B45","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1111\/j.1365-2265.2011.04159.x","article-title":"A concerted decline in insulin secretion and action occurs across the spectrum of fasting and postchallenge glucose concentrations","volume":"76","author":"Sathananthan","year":"2012","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2022031303570601500_B46","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1042\/BST0360950","article-title":"The long-chain fatty acid receptor, GPR40, and glucolipotoxicity: investigations using GPR40-knockout mice","volume":"36","author":"Brownlie","year":"2008","journal-title":"Biochem Soc Trans"},{"key":"2022031303570601500_B47","doi-asserted-by":"crossref","first-page":"S16","DOI":"10.2337\/db06-S003","article-title":"Fatty acid signaling in the beta-cell and insulin secretion","volume":"55","author":"Nolan","year":"2006","journal-title":"Diabetes"},{"key":"2022031303570601500_B48","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1016\/j.cmet.2014.04.005","article-title":"The role of \u03b2 cell glucagon-like peptide-1 signaling in glucose regulation and response to diabetes drugs","volume":"19","author":"Smith","year":"2014","journal-title":"Cell Metab"}],"container-title":["Diabetes"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/diabetes.diabetesjournals.org\/syndication\/doi\/10.2337\/db15-1233","content-type":"unspecified","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/journals.org\/diabetes\/diabetes\/article-pdf\/65\/2\/371\/582216\/db151233.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/diabetesjournals.org\/diabetes\/article-pdf\/65\/2\/371\/582216\/db151233.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,2]],"date-time":"2022-11-02T16:48:27Z","timestamp":1667407707000},"score":1,"resource":{"primary":{"URL":"https:\/\/diabetesjournals.org\/diabetes\/article\/65\/2\/371\/40201\/TCF7L2-Genotype-and-Cell-Function-in-Humans"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,11,2]]},"references-count":48,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2015,11,2]]},"published-print":{"date-parts":[[2016,2,1]]}},"URL":"https:\/\/doi.org\/10.2337\/db15-1233","relation":{},"ISSN":["0012-1797","1939-327X"],"issn-type":[{"value":"0012-1797","type":"print"},{"value":"1939-327X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,11,2]]}}}